AnalystsMike MatsonMike Matson's Stock Forecasts
AnalystsMike Matson
Analyst Ranking
Bottom 1%
#4590 out of 4598 analysts
Average Return
-7.76%
Win Rate
40%130 out of 327
Risk vs Reward
Poor
Good
Mike Matson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cantel Medical CorpCMD | +158.06% | $31.93 | $82.40 | 2020-05-11 - 2021-01-13 | Buy |
Hologic IncHOLX | +102.55% | $34.06 | $68.99 | 2020-04-01 - 2020-11-20 | Buy |
Shockwave Medical IncSWAV | +87.86% | $178.19 | $334.75 | 2023-11-06 - 2024-05-30 | Buy |
Artivion IncAORT | +64.44% | $14.23 | $23.40 | 2023-11-02 - 2024-06-11 | Buy |
Zimmer Biomet Holdings IncZBH | +59.70% | $101.91 | $162.75 | 2020-04-06 - 2021-04-07 | Strong Buy |
Mike Matson Analyst Color
Get additional color on Mike Matson's coverage of popular stocks
Mike Matson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Livanova PLCLIVN | 18 | Buy | $72.00 | +39.10% | Reiterates | 6 days ago |
Stryker CorpSYK | 1 | Buy | $392.00 | +13.16% | Upgrades | 22 days ago |
Oncocyte CorpOCX | 12 | Buy | $4.25 | +55.11% | Reiterates | a month ago |
Lucid Diagnostics IncLUCD | 14 | Buy | $2.50 | +244.83% | Reiterates | a month ago |
Paragon 28 IncFNA | 12 | Buy | $14.00 | +111.48% | Maintains | a month ago |
Personalis IncPSNL | 13 | Buy | $3.50 | +163.16% | Reiterates | a month ago |
Veracyte IncVCYT | 11 | Buy | $27.00 | +26.82% | Maintains | a month ago |
Orthopediatrics CorpKIDS | 13 | Buy | $42.00 | +40.94% | Maintains | a month ago |
Artivion IncAORT | 16 | Buy | $30.00 | +28.21% | Maintains | a month ago |
Conmed CorpCNMD | 17 | Buy | $107.00 | +43.97% | Reiterates | a month ago |
Enovis CorpENOV | 9 | Buy | $82.00 | +83.32% | Reiterates | a month ago |
Hologic IncHOLX | 9 | Buy | $90.00 | +23.46% | Reiterates | a month ago |
Atricure IncATRC | 21 | Buy | $40.00 | +82.48% | Maintains | a month ago |
Surmodics IncSRDX | 14 | Buy | $43.00 | +2.75% | Maintains | a month ago |
Merit Medical Systems IncMMSI | 15 | Buy | $85.00 | +3.14% | Maintains | a month ago |
Inari Medical IncNARI | 4 | Buy | $57.00 | +19.82% | Maintains | a month ago |
Neogenomics IncNEO | 17 | Buy | $19.00 | +44.38% | Maintains | a month ago |
Resmed IncRMD | 7 | Buy | $236.00 | +12.28% | Maintains | 2 months ago |
Boston Scientific CorpBSX | 18 | Buy | $82.00 | +6.29% | Maintains | 2 months ago |
Shockwave Medical IncSWAV | 6 | Buy | $286.00 | -14.56% | Maintains | 4 months ago |
Masimo CorpMASI | 12 | Buy | $86.00 | -30.74% | Maintains | 7 months ago |
Axonics IncAXNX | 15 | Buy | $63.00 | -5.97% | Maintains | 7 months ago |
Inogen IncINGN | 7 | Buy | $26.00 | N/A | Reiterates | a year ago |
Teleflex IncTFX | 4 | Buy | $291.00 | N/A | Reiterates | a year ago |
Penumbra IncPEN | 4 | Buy | $300.00 | N/A | Maintains | a year ago |
Inmode LtdINMD | 8 | Buy | $60.00 | N/A | Reiterates | a year ago |
Steris PLCSTE | 6 | Hold | N/A | N/A | Downgrades | 2 years ago |
Medtronic PLCMDT | 7 | Hold | N/A | N/A | Downgrades | 2 years ago |
Zimmer Biomet Holdings IncZBH | 15 | Hold | N/A | N/A | Downgrades | 2 years ago |
Cardiovascular Systems IncCSII | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Invacare CorpIVCRQ | 1 | Buy | $8.00 | N/A | Maintains | 3 years ago |
Haemonetics CorpHAE | 5 | Buy | $108.00 | N/A | Maintains | 3 years ago |
Genmark Diagnostics IncGNMK | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Si Bone IncSIBN | 1 | Buy | $34.00 | N/A | Maintains | 3 years ago |
Globus Medical IncGMED | 1 | Buy | $75.00 | N/A | Maintains | 3 years ago |
Cantel Medical CorpCMD | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hill Rom Holdings IncHRC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Nuvasive IncNUVA | 1 | Buy | $74.00 | N/A | Upgrades | 4 years ago |
Wright Medical Group NvWMGI | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.